Condition

Stage IIIB Ovarian Cancer AJCC v8

ClinicalTrials.gov condition label

Clinical trials8

Recruiting1

Common interventions16

Lead sponsors shown7

Clinical trials

8 shown

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxNCT05092373 · 2022-04-29

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer SurvivorsNCT07259304 · 2021-11-24

ACTIVE_NOT_RECRUITING

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesNCT04501913 · 2019-12-24

A Phase I Study of SOR-C13 in Patients With Advanced Solid TumorsNCT03784677 · 2019-07-29

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyNCT03707574 · 2019-07-16

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerNCT04067960 · 2019-06-06

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerNCT03939481 · 2019-05-14

ACTIVE_NOT_RECRUITING

Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic InstabilityNCT03428802 · 2018-03-08

ACTIVE_NOT_RECRUITING

Common interventions

Questionnaire AdministrationOTHER3 Biospecimen CollectionPROCEDURE2 Quality-of-Life AssessmentOTHER2 AtezolizumabBIOLOGICAL1 Cabozantinib S-malateDRUG1 ChemotherapyDRUG1 Functional AssessmentOTHER1 Genetic TestingOTHER1 Laboratory Biomarker AnalysisOTHER1 Medical Device Usage and EvaluationOTHER1 Nab-paclitaxelDRUG1 Patient MonitoringPROCEDURE1 PembrolizumabBIOLOGICAL1 Survey AdministrationOTHER1 TRPV6 Calcium Channel Inhibitor SOR-C13DRUG1 Tumor Treating Fields TherapyPROCEDURE1

Leading sponsors

M.D. Anderson Cancer Center2 City of Hope Medical Center1 Mayo Clinic1 National Cancer Institute (NCI)1 Rutgers, The State University of New Jersey1 SWOG Cancer Research Network1 University of Southern California1

Trial status mix

COMPLETED4

ACTIVE_NOT_RECRUITING3

RECRUITING1

Phase mix

PHASE12

EARLY_PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.